Brian Halligan, Chief Executive Officer and Director of HubSpot Inc., filed a Form 4 on November 16, 2026, disclosing a purchase of common stock on November 13, 2026, that the filing states resulted in a short-swing profit subject to repayment under Section 16(b) of …
Director John Rae Hastings of Csquare, Inc. filed a statement of changes in beneficial ownership on November 16, 2026, disclosing the acquisition of 6,439 restricted stock units on October 29, 2026.
Director and 10% owner Gregg Williams filed a Form 4 with the SEC on November 16, 2026, disclosing an open-market purchase of 48,100 shares of Vivani Medical, Inc. common stock on November 13, 2026.
Director Faith L. Charles filed a Form 4 with the SEC on November 16, 2026, disclosing a purchase of 15,000 shares of Abeona Therapeutics Inc. common stock on November 13, 2026.
Director Terri Pizzuto filed a Form 4 with the SEC on November 16, 2026, disclosing an open market purchase of common stock and a restricted stock unit grant at Csquare, Inc. (NASDAQ:CSQR).
Director Mats Wahlstrom filed a Form 4 with the SEC on November 16, 2026, disclosing a purchase of 50,000 shares of TriSalus Life Sciences, Inc. common stock on November 12, 2026.
Smriti Laxman Popenoe, Co-CEO and President of Dynex Capital Inc., filed a Form 4 on November 16, 2026, disclosing a purchase of 2,600 shares of common stock on November 13, 2026.
Byron L. Boston, Co-CEO and Chairman of the Board of Dynex Capital Inc., filed a Form 4 on November 16, 2026, disclosing an open-market purchase of common stock on November 13, 2026.
Director Lori A. Woods filed a Form 4 with the SEC on November 16, 2026, disclosing an open-market purchase of common stock in Perspective Therapeutics, Inc. (NYSE:CATX) on November 12, 2026.
PureCycle Technologies, Inc. Executive Chairman Fernando Musa filed a Form 4 on November 16, 2026, disclosing an open-market purchase of common stock on November 13, 2026.